It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but ...

Recursion Pharmaceuticals, Inc. ( NASDAQ: RXRX) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 4:05 PM EDT ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Autonomous AI agents are more than just extensions of vendor tools. They’re credentialed actors who connect and execute, and ...

Insitro, Firefly Bio and Superluminal Medicines are among the first participants in Lilly’s “TuneLabs” platform, which the ...

Eliezer Yudkowsky and Nate Soares argue AI could legitimately take over the world in their new book, If Anyone Builds it, ...

Magic: The Gathering underwent some changes with Edge of Eternities, with a popular card being "nerfed" on account of MTG ...

Hamilton, Bermuda, September 11th, 2025, ChainwireOnRe, an onchain asset manager delivering institutional-grade yield to ...

On September 1st, the author and statistician Nate Silver wrote a post on X diagnosing a new condition: “Blueskyism,” so ...

It isn’t fair to say that user centered design is gone—yet. It’s still here, but the target users have changed. We used to be ...

CrowdStrike Holdings, Inc. ( NASDAQ: CRWD) Goldman Sachs Communacopia + Technology Conference 2025 September 9, 2025 2:30 PM ...

Saylor, long known as the co-founder and head of enterprise-software firm Strategy (previously MicroStrategy), made his first ...